Topical Drug Delivery Market will grow at highest pace owing to rising preference for localized therapy
Topical
Drug Delivery comprises the administration of pharmaceutical active ingredients
to the skin, eye or mucosa. The products are formulated for topical
administration in various dosage forms like semi-solid, liquid, and solid
formulations for superficial or transdermal drug delivery. Topical drug
delivery has numerous advantages over other forms of delivery like targeted
delivery which reduces systemic absorption and unwanted effects. It provides
advantages such as self-administration, needle-free delivery, and ease of use.
With the growing demand for localized and targeted therapy, topical drug
delivery has emerged as a suitable alternative for conventional routes of administration
in conditions like dermatology, ophthalmology, and other localized disorders.
The Global Topical Drug Delivery Market is estimated to be valued at US$ 124.90
Bn in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period
2024 To 2031.
Key Takeaways
Key players operating in the Topical Drug Delivery are Johnson & Johnson,
Pfizer Inc., Novartis International AG, GSK plc, Bayer AG, Merck & Co.,
Inc., Sanofi, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Eli Lilly and
Company, Galderma Laboratories, L.P., Viatris Inc., Sun Pharmaceutical
Industries Ltd., Perrigo Company plc, Bausch Health Companies Inc., Taro
Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., and Almirall
S.A.
The growing demand for topical drugs can be attributed to the increasing
prevalence of skin diseases and disorders such as acne, dermatitis, psoriasis,
wound healing and other infections. Topical
Drug Delivery Market Size As per the International Federation of
Psoriasis Associations, over 125 million people worldwide suffer from
psoriasis. This has fuelled the demand for localized and targeted drugs.
Technological advancements in topical drug formulations including transdermal
drug delivery systems, use of nanotechnology and personalized medicines have
augmented efficient transdermal drug delivery. Noval drug delivery mechanisms
like ethosomes, transfersomes and polymeric nanoparticles have enabled enhanced
efficacy and stability of active ingredients.
Market Trends
The increasing focus on advanced topical drug delivery systems and emergence of
new carriers have revolutionized the segment. Novel technologies like
lipid-based nanocarriers, hydrogels, and polymer-based nanocarriers have
facilitated controlled and sustained release, boosting efficacy.
Recent advancements include the development of active and passive patch
systems, gels, and foams incorporating nanotechnology and stimuli-responsive
polymers. Patches and films provide formulated drugs at pre-determined rates
for prolonged periods.
Market Opportunities
Growing demand for generic topical drugs due to patent expiries of blockbuster
brands will open lucrative opportunities. As per estimates over US$ 10 Bn worth
of branded topical drugs will lose exclusivity between 2018 to 2024.
Increasing focus on developing topical biologics, peptides and cell-based
therapies for various conditions like psoriasis, atopic dermatitis, wound
healing presents a remunerative avenue. They offer high potency and new
mechanisms of action.
The COVID-19 pandemic has significantly impacted the growth of the topical drug
delivery market. During the pandemic, many medical facilities shifted their
focus to treating COVID cases, leading to postponement of non-essential
treatments and procedures. This negatively impacted the demand for topical drugs
in categories such as dermatology and ophthalmology. Additionally, social
distancing measures and lockdowns restricted people's movement, reducing
patient visits to physicians and limiting product availability through pharmacy
channels. The supply chain disruptions during the initial months of 2020
further hindered new product development and launches.
However, as the pandemic has progressed, some trends emerged that provided new
opportunities for topical drug delivery growth. There was increased demand for
prescription and over-the-counter topical drugs used for wound care, pain
relief, and infection control. The availability of telemedicine further
facilitated access to prescription topical drugs. Pharmaceutical companies
responded to the crisis by increasing production of essential drugs, developing
new formulations suitable for pandemic conditions, and strengthening
omni-channel distribution networks. Going forward, continued digitalization of
healthcare and focus on drug delivery methods requiring minimal healthcare
resource utilization are expected to benefit the topical drug delivery market
growth in the post-COVID era.
In terms of geography, North America currently accounts for the largest share
of the global topical drug delivery market, both in terms of value and volume.
This is attributed to factors such as high healthcare expenditure, availability
of advanced treatment options, and presence of major market players in the
region. Within North America, the United States holds the major market share
due to high disease prevalence and strong demand for prescription and OTC
topical drugs. The Asia Pacific region is expected to witness the fastest
growth during the forecast period due to increasing patient awareness,
healthcare investments, and rapidly developing pharmaceutical industry in
countries like India and China.
For the topical drug delivery market, Western Europe accounts for the second
largest regional market globally due to advanced healthcare facilities and
rising research funding for new product development. Within Western Europe,
Germany has emerged as the largest market due to high per capita healthcare
spending and presence of leading topical drug manufacturers. Another fast
growing region for this market is Latin America, driven by economic growth,
healthcare reforms, and rising demand for affordable treatments. Brazil and
Mexico specifically are expected to provide significant opportunities for
topical drug delivery market participants.
Get more insights on This Topic- Topical
Drug Delivery Market
Comments
Post a Comment